Search - tctmd.com

Displaying 561 - 580 of 1032

Sort: Relevancy | Date

Podcast TCTMD Talking Points

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

September 06, 2017

Presentation iASSESS 2017

Aspirin and ADP Antagonists Pre and Post Coronary Stent Implantation

Presenter: Dmitriy N. Feldman

August 30, 2017

Presentation iASSESS 2017

iASSESS: Intervention for Venous Disease

Presenter: Vishal Kapur

August 30, 2017

News Daily News

Prolonged Standing at Work Linked to Increased CV Risk

L.A. McKeown

August 21, 2017

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

News Daily News

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Todd Neale

July 12, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Daily News

Inferior Vena Cava Filters: The Longer They’re In, the Higher the Risk of Adverse Events

L.A. McKeown

June 19, 2017

News Daily News

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Yael L. Maxwell

May 10, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Daily News

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Yael L. Maxwell

April 11, 2017

Presentation Fellows 2017

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Ajay J. Kirtane, Emmanouil S. Brilakis

April 08, 2017

News Daily News

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

Shelley Wood

April 07, 2017

Presentation ACC 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presenter: Jeff Weitz

March 20, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

L.A. McKeown

March 18, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

FDA Warns Against Off-Label Use of Balloon Angioplasty to Treat Autonomic Dysfunction

Yael L. Maxwell

March 08, 2017

News Daily News

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

Yael L. Maxwell

February 24, 2017

Advertisement

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

Aspirin and ADP Antagonists Pre and Post Coronary Stent Implantation

iASSESS: Intervention for Venous Disease

Prolonged Standing at Work Linked to Increased CV Risk

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Betrixaban Approved for Prevention of VTE

Inferior Vena Cava Filters: The Longer They’re In, the Higher the Risk of Adverse Events

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

LivaNova Acquires Caisson Interventional, LLC

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Live From Washington: ACC 2017, Day Two

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

FDA Warns Against Off-Label Use of Balloon Angioplasty to Treat Autonomic Dysfunction

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content